Operator

Thank you for standing by, and welcome to the Balchem's First Quarter 2026 Earnings Conference Call. [Operator Instructions]

I'd now like to turn the call over to Martin Bengtsson, Chief Financial Officer. You may begin.

Carl Bengtsson
Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health

Thank you. Good morning, everyone. Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending March 31, 2026. My name is Martin Bengtsson, Chief Financial Officer; and hosting this call with me is Ted Harris, our Chairman, President and CEO.

Following the advice of our counsel, auditors and the SEC, at this time, I would like to read our forward-looking statements. Statements made in today's call that are not historical facts are considered forward-looking statements. We can give no assurance that the expectations reflected in forward-looking statements will prove correct, and various factors could cause actual results to differ materially from our expectations, including risks and factors identified in Balchem's most recent Form 10-K, 10-Q and 8-K reports. The company assumes no obligation to update these forward-looking statements.

Today's call and commentary also include non-GAAP financial measures. Please refer to the reconciliations in our earnings release for further details.

I will now turn the call over to Ted Harris, our Chairman, President and CEO.

Theodore Harris
CEO, President & Chairman

Thanks, Martin. Good